Twin Tree Management, LP Bio N Tech Se Call Options Transaction History

Twin Tree Management, LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$78.36 - $124.66 $391,800 - $623,300	5,000 New	5,000 $593,000
Q1 2022 May 11, 2022	BUY	$126.25 - $231.85 $6.15 Million - $11.3 Million	48,700 Added 80.36%	109,300 $18.6 Million
Q4 2021 Feb 10, 2022	SELL	$216.64 - $362.52 $21,664 - $36,252	-100 Reduced 0.16%	60,600 $15.6 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $5.66 Million - $12.3 Million	27,500 Added 82.83%	60,700 $16.6 Million
Q2 2021 Aug 12, 2021	SELL	$113.32 - $241.49 $10.2 Million - $21.7 Million	-89,700 Reduced 72.99%	33,200 $7.43 Million
Q1 2021 May 17, 2021	BUY	$85.73 - $119.5 $10.5 Million - $14.7 Million	122,900 New	122,900 $13.4 Million

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.